Periodic Reporting for period 2 - INPACT (Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.)

INPACT has a collaborative academic and industrial R&D team that combines specific technologies and expertise in peptide science, proprietary technologies on antibody and protein engineering, and experience in development of antimicrobial and anticancer drugs. Together this...